| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | heat shock protein binding | 1.05e-04 | 163 | 177 | 8 | GO:0031072 | |
| GeneOntologyMolecularFunction | Hsp90 protein binding | 1.26e-04 | 55 | 177 | 5 | GO:0051879 | |
| GeneOntologyCellularComponent | clathrin coat of trans-Golgi network vesicle | 1.42e-05 | 18 | 178 | 4 | GO:0030130 | |
| GeneOntologyCellularComponent | trans-Golgi network transport vesicle membrane | 3.30e-05 | 22 | 178 | 4 | GO:0012510 | |
| GeneOntologyCellularComponent | Golgi-associated vesicle membrane | 1.71e-04 | 61 | 178 | 5 | GO:0030660 | |
| GeneOntologyCellularComponent | clathrin vesicle coat | 2.99e-04 | 38 | 178 | 4 | GO:0030125 | |
| GeneOntologyCellularComponent | trans-Golgi network transport vesicle | 3.66e-04 | 40 | 178 | 4 | GO:0030140 | |
| Domain | ARM-type_fold | CLTCL1 IFT172 MROH2A UBR4 MROH5 ARFGEF2 APOB UNC45A MEI1 RALGAPA2 EFR3A AP2A1 AP1B1 PIK3C2A CLTC UTP20 | 9.49e-08 | 339 | 171 | 16 | IPR016024 |
| Domain | Clathrin_H-chain_propeller_rpt | 8.33e-05 | 2 | 171 | 2 | IPR022365 | |
| Domain | Clathrin-link | 8.33e-05 | 2 | 171 | 2 | PF09268 | |
| Domain | - | 8.33e-05 | 2 | 171 | 2 | 2.130.10.110 | |
| Domain | Clathrin_heavy_chain | 8.33e-05 | 2 | 171 | 2 | IPR016341 | |
| Domain | Clathrin_H-chain_propeller_N | 8.33e-05 | 2 | 171 | 2 | IPR001473 | |
| Domain | Clathrin_H-chain_link/propller | 8.33e-05 | 2 | 171 | 2 | IPR016025 | |
| Domain | Clathrin_propel | 8.33e-05 | 2 | 171 | 2 | PF01394 | |
| Domain | Clathrin_H-chain_linker_core | 8.33e-05 | 2 | 171 | 2 | IPR015348 | |
| Domain | Clathrin_H-chain_linker | 2.49e-04 | 3 | 171 | 2 | IPR012331 | |
| Domain | Oest-rel_rcp | 2.49e-04 | 3 | 171 | 2 | IPR027289 | |
| Domain | CLH | 2.49e-04 | 3 | 171 | 2 | SM00299 | |
| Domain | TPR-like_helical_dom | 3.04e-04 | 233 | 171 | 9 | IPR011990 | |
| Domain | Nebulin | 4.94e-04 | 4 | 171 | 2 | PF00880 | |
| Domain | NEBULIN | 4.94e-04 | 4 | 171 | 2 | PS51216 | |
| Domain | NEBU | 4.94e-04 | 4 | 171 | 2 | SM00227 | |
| Domain | Nebulin | 4.94e-04 | 4 | 171 | 2 | IPR013998 | |
| Domain | Nebulin_repeat | 4.94e-04 | 4 | 171 | 2 | IPR000900 | |
| Pubmed | CERK SPAM1 EP400 MAP1A UACA VWA8 ABCA12 HMGXB4 RALGAPA2 SIRT1 NSD3 NCOR2 NAA35 GTF2H1 PBRM1 KMT5B CHD5 PIP4K2A USP7 FMN2 PIP4K2B ZFHX3 ADAM17 KDM1B CDC27 EP300 ARAP2 | 2.92e-11 | 1116 | 180 | 27 | 31753913 | |
| Pubmed | NEBL EP400 UACA HMGXB4 UNC45A TTF1 ESF1 NSD3 EFR3A METAP1 GTF2H1 CEPT1 PBRM1 SHANK2 SLC12A2 PIK3C2A PHF3 UBP1 USP7 PDCD11 CRYBG1 UTP20 ZFHX3 STIP1 EIF3A EIF3F KDM1B CDC27 ZHX1 SF3A2 SMG6 | 4.28e-11 | 1497 | 180 | 31 | 31527615 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | VAPB DMXL2 MAP1A SHANK3 PTK2B SHANK2 AP2A1 AP1B1 PHF3 GNA13 CLTC STIP1 RIMS2 | 3.06e-09 | 281 | 180 | 13 | 28706196 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | HMGXB4 ARHGAP11A SGO1 ZEB2 SIRT1 NSD3 PBRM1 THYN1 FAM50A PHF3 UBTF GLYR1 CHD5 USP7 KDM1B CDC27 ZHX1 | 2.16e-08 | 608 | 180 | 17 | 36089195 |
| Pubmed | ERCC4 EP400 RBM10 UBR4 HMGXB4 LARP1 SPAG9 SPATA2 ZEB2 SIRT1 NCOR2 PBRM1 UBTF GLYR1 CHD5 SYNE2 USP7 PDCD11 ZFHX3 STIP1 EIF3A EIF3F KDM1B ZHX1 EP300 FILIP1L | 2.66e-08 | 1429 | 180 | 26 | 35140242 | |
| Pubmed | VAPB MYH6 CLTCL1 UBR4 LARP1 ATP10B APOB NEB SGO1 CXorf65 ZEB2 ESF1 LIG4 SHANK2 AP2A1 FAM50A GNA13 CHD5 SYNE2 PIP4K2A CLTC PIP4K2B EIF3A RIMS2 CDC27 SF3A2 | 3.18e-08 | 1442 | 180 | 26 | 35575683 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | UACA EXPH5 LARP1 UNC45A ITGA4 ARHGAP11A IFI16 ESF1 NSD3 GTF2H1 AP2A1 PHF3 UBTF GLYR1 CHD5 CLTC USP7 CSTA PDCD11 CRYBG1 UTP20 EIF3A EIF3F SF3A2 | 3.95e-08 | 1257 | 180 | 24 | 36526897 |
| Pubmed | VAPB DMXL2 UACA VWA8 UBR4 MRPL45 UNC45A DNAJB9 SIRT1 ESF1 EFR3A NAA35 SLC12A2 PPP5C PIK3C2A UBTF GLYR1 ASNS SYNE2 CLTC PDCD11 TMEM131 STIP1 DNAJB5 GPAT4 GOLGA3 | 5.84e-08 | 1487 | 180 | 26 | 33957083 | |
| Pubmed | ANXA6 UBR4 LARP1 SPAG9 TTF1 ESF1 PBRM1 AP1B1 PHF3 UBTF GLYR1 ASNS SYNE2 CLTC USP7 PDCD11 UTP20 | 6.04e-08 | 653 | 180 | 17 | 22586326 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | CACNA1F EPB41L4B UBR4 LARP1 SPAG9 ARHGAP11A ZNF831 CHN1 FAM186B THYN1 ASNS CLTC FMN2 UTP20 STIP1 EIF3A CFAP44 ELP4 | 6.19e-08 | 736 | 180 | 18 | 29676528 |
| Pubmed | PDGFRA ESRRG UBR4 HMGCR DNAJB9 METTL23 SMC5 PAPSS2 FAM186B SIRT1 ESF1 NAA35 CEPT1 PBRM1 KMT5B FAM50A UBP1 UBTF GNA13 CLTC USP7 STIP1 CDC25A EP300 | 1.08e-07 | 1327 | 180 | 24 | 32694731 | |
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | CABLES2 EP400 PDGFRA ZRSR2 ESRRG LARP1 ZNF510 NEB SIRT1 GTF2H1 SHANK2 PPP5C PHF3 USP7 PDCD11 STIP1 EP300 | 1.46e-07 | 695 | 180 | 17 | 23602568 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | EP400 RASA2 UBR4 UNC45A PAPSS2 IFI16 ESF1 NCOR2 NAA35 GTF2H1 AP2A1 PIK3C2A UBTF GLYR1 ASNS PIP4K2A CLTC USP7 CSTA PDCD11 UTP20 EIF3A EIF3F CDC27 | 1.53e-07 | 1353 | 180 | 24 | 29467282 |
| Pubmed | 1.74e-07 | 116 | 180 | 8 | 30804394 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | EP400 LARP1 MRPL45 IDE ZEB2 NCOR2 PBRM1 UBP1 SYNE2 PIP4K2A USP7 STIP1 EP300 | 1.82e-07 | 398 | 180 | 13 | 35016035 |
| Pubmed | DMXL2 ZRSR2 FOLH1 IFT172 UBR4 ARFGEF2 ZNF227 DNAJB9 ZEB2 ITGB8 METAP1 PPP5C AP2A1 VPS35L USP32 CLTC USP7 FMN2 TMEM131 EIF3F SF3A2 EP300 GOLGA3 | 2.44e-07 | 1285 | 180 | 23 | 35914814 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | VAPB VWA8 MRPL45 UNC45A SPATA2 SIRT1 PPP5C PIK3C2A GNA13 USP32 USP7 CSTA STIP1 EIF3A MPHOSPH9 EIF3F KDM1B CDC25A CDC27 SF3A2 | 3.06e-07 | 1005 | 180 | 20 | 19615732 |
| Pubmed | EP400 UBR4 UNC45A SMC5 IFI16 SIRT1 ESF1 NSD3 NCOR2 PBRM1 FAM50A PHF3 UBTF ASNS USP7 EIF3A EIF3F KDM1B SF3A2 EP300 | 3.52e-07 | 1014 | 180 | 20 | 32416067 | |
| Pubmed | VAPB CLTCL1 UACA VWA8 ANXA6 UBR4 LARP1 HMGCR MRPL45 UNC45A ARHGAP11A IFI16 PIK3C2A UBTF ASNS SYNE2 VPS35L CLTC USP7 CSTA PDCD11 STIP1 EIF3A EIF3F | 4.71e-07 | 1440 | 180 | 24 | 30833792 | |
| Pubmed | HIP1 functions in clathrin-mediated endocytosis through binding to clathrin and adaptor protein 2. | 5.43e-07 | 4 | 180 | 3 | 11517213 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | EP400 UBR4 HMGXB4 LARP1 SPAG9 MRPL45 TTF1 ZEB2 NCOR2 LIG4 UBP1 GLYR1 CSTA UTP20 KDM1B CDC25A CDC27 EP300 | 5.75e-07 | 857 | 180 | 18 | 25609649 |
| Pubmed | PPP1R21 CLTCL1 PDGFRA ANXA6 UBR4 ARFGEF2 LARP1 ITGA4 IFI16 NCOR2 AP2A1 PIK3C2A GNA13 CHD5 CLTC ADAM17 EIF3A MPHOSPH9 EIF3F GPAT4 GOLGA3 | 7.89e-07 | 1168 | 180 | 21 | 19946888 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ENOSF1 CABLES2 FUT10 RASA2 UACA EPB41L4B FOLH1 ANXA6 LARP1 IDE TTF1 GRHL2 NAALADL2 KRCC1 NCOR2 FAM111A SHANK2 GLYR1 VPS35L ZFHX3 ZNF839 CYP4F11 EP300 SMG6 | 8.52e-07 | 1489 | 180 | 24 | 28611215 |
| Pubmed | 1.01e-06 | 101 | 180 | 7 | 9872452 | ||
| Pubmed | VAPB PPP1R21 DMXL2 ANXA6 UBR4 NEB GBA2 AP1B1 SYNE2 USP32 EIF3A | 1.06e-06 | 322 | 180 | 11 | 26514267 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | VAPB EP400 RBM10 HMGXB4 ARHGAP11A IFI16 TTF1 NSD3 NCOR2 PBRM1 AP2A1 PHF3 UBP1 UBTF GLYR1 USP7 PDCD11 UTP20 KDM1B CDC27 SF3A2 EP300 | 1.07e-06 | 1294 | 180 | 22 | 30804502 |
| Pubmed | EXOC6 RASA2 ANXA6 UBR4 IDE ZNF227 NEB ESF1 MEPE NCOR2 PBRM1 AP1B1 UBP1 SYNE2 EP300 | 1.33e-06 | 638 | 180 | 15 | 31182584 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | CABLES2 MYH6 TRAF1 UACA ESF1 PTK2B NCOR2 NEK3 GTF2H1 AP2A1 AP1B1 NRK PIP4K2A USP7 PIP4K2B EIF3F CDC27 EP300 | 1.35e-06 | 910 | 180 | 18 | 36736316 |
| Pubmed | 1.35e-06 | 5 | 180 | 3 | 10436022 | ||
| Pubmed | UACA LARP1 IFI16 ESF1 PBRM1 UBTF GLYR1 PIP4K2A USP7 PDCD11 UTP20 | 1.43e-06 | 332 | 180 | 11 | 25693804 | |
| Pubmed | VAPB UBR4 ARFGEF2 LARP1 SIRT1 PHAF1 NCOR2 UBP1 PIP4K2B TMEM131 SMG6 | 1.56e-06 | 335 | 180 | 11 | 15741177 | |
| Pubmed | KANSL1L DMXL2 MYOM1 UACA ESRRG NEB PPP5C PIK3C2A SYNE2 CLTC STIP1 EIF3A DNAJB5 | 2.18e-06 | 497 | 180 | 13 | 23414517 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 2.41e-06 | 220 | 180 | 9 | 35785414 | |
| Pubmed | VAPB SPAG9 IDE SGO1 ESF1 NSD3 EFR3A NCOR2 SLC12A2 PPP5C UBTF GLYR1 SYNE2 CLTC USP7 FMN2 STIP1 MPHOSPH9 CDC25A | 2.46e-06 | 1049 | 180 | 19 | 27880917 | |
| Pubmed | 2.60e-06 | 222 | 180 | 9 | 37071664 | ||
| Pubmed | VAPB EP400 UACA VWA8 ANXA6 LARP1 APOB UNC45A DNAJB9 TTF1 PBRM1 FAM111A THYN1 AP2A1 AP1B1 PIK3C2A FAM50A PHF3 GLYR1 CLTC CSTA PDCD11 | 2.73e-06 | 1371 | 180 | 22 | 36244648 | |
| Pubmed | EXPH5 UBR4 ARFGEF2 ZNF510 UNC45A TTF1 ZEB2 METAP1 NCOR2 PBRM1 AP2A1 AP1B1 EIF3F SF3A2 | 2.79e-06 | 591 | 180 | 14 | 15231748 | |
| Pubmed | 4.26e-06 | 177 | 180 | 8 | 26206133 | ||
| Pubmed | Clathrin interacts specifically with amphiphysin and is displaced by dynamin. | 4.70e-06 | 7 | 180 | 3 | 9280305 | |
| Pubmed | VAPB ERCC4 EP400 RBM10 SMC5 IFI16 GTF2H1 FAM111A PHF3 KDM1B ZHX1 EP300 | 4.77e-06 | 453 | 180 | 12 | 29656893 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | VAPB TRAF1 ANXA6 UBR4 LARP1 APOB IDE UNC45A ESF1 PBRM1 PPP5C AP2A1 UBTF GLYR1 ASNS CLTC USP7 CSTA PDCD11 UTP20 STIP1 EIF3A | 5.05e-06 | 1425 | 180 | 22 | 30948266 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | RIN3 CLTCL1 EP400 VWA8 UBR4 ARFGEF2 RALGAPA2 GBA2 NSD3 NCOR2 SHANK2 AP2A1 CHD5 USP7 PDCD11 ZNF839 GPAT4 EP300 SMG6 | 5.19e-06 | 1105 | 180 | 19 | 35748872 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | VAPB CLTCL1 UBR4 LARP1 GBP3 PAPSS2 NAA35 SLC12A2 AP2A1 AP1B1 CLTC USP7 ZFHX3 STIP1 EIF3A EIF3F | 5.21e-06 | 807 | 180 | 16 | 30575818 |
| Pubmed | EP400 RBM10 LARP1 SPAG9 UNC45A ESF1 NSD3 PHF3 CLTC USP7 PDCD11 EP300 ELP4 | 6.41e-06 | 549 | 180 | 13 | 38280479 | |
| Pubmed | EP400 SPAG9 ARHGAP11A SGO1 NSD3 PBRM1 AP2A1 FAM50A GLYR1 PIP4K2A PIP4K2B MPHOSPH9 KDM1B EP300 | 7.54e-06 | 645 | 180 | 14 | 25281560 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | VAPB NEBL UACA EPB41L4B LARP1 UNC45A EFR3A SHANK2 SLC12A2 CRYBG1 ADAM17 ELP4 GOLGA3 | 8.70e-06 | 565 | 180 | 13 | 25468996 |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | UACA EPB41L4B EXPH5 ARFGEF2 APOB RALGAPA2 EFR3A FRMD4A SLC12A2 NRK USP32 FMN2 ARAP2 | 9.38e-06 | 569 | 180 | 13 | 30639242 |
| Pubmed | 9.49e-06 | 26 | 180 | 4 | 24067654 | ||
| Pubmed | RBM10 LARP1 UNC45A IFI16 NSD3 CEPT1 PBRM1 PHF3 UBP1 UBTF GLYR1 PDCD11 UTP20 EIF3A EIF3F SF3A2 | 9.51e-06 | 847 | 180 | 16 | 35850772 | |
| Pubmed | EP400 IFT172 RBM10 SMC5 SPATA2 ZEB2 FCHSD2 PHF3 RHOBTB2 CLTC ARAP2 | 9.94e-06 | 407 | 180 | 11 | 12693553 | |
| Pubmed | Clint: a novel clathrin-binding ENTH-domain protein at the Golgi. | 1.12e-05 | 9 | 180 | 3 | 12429846 | |
| Pubmed | Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins. | VAPB IMPA1 UBR4 APOB DNAJB9 CEPT1 AP2A1 GLYR1 USP7 DNAJB5 GPAT4 EP300 | 1.26e-05 | 499 | 180 | 12 | 22810586 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | EP400 UACA RBM10 ARFGEF2 LARP1 SPAG9 IFI16 SIRT1 ESF1 NCOR2 PHF3 CLTC USP7 UTP20 ZHX1 | 1.35e-05 | 774 | 180 | 15 | 15302935 |
| Pubmed | VAPB DMXL2 ARFGEF2 SLC12A2 SYNE2 VPS35L USP32 FMN2 TMEM131 ADAM17 GPAT4 GOLGA3 | 1.39e-05 | 504 | 180 | 12 | 34432599 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | DMXL2 EP400 MAP1A VWA8 ZRSR2 RBM10 ANXA6 HMGXB4 MRPL45 NSD3 THYN1 AP2A1 GLYR1 CLTC USP7 EIF3F KDM1B SF3A2 | 1.45e-05 | 1082 | 180 | 18 | 38697112 |
| Pubmed | Characterization of gene expression in mouse blastocyst using single-pass sequencing of 3995 clones. | 1.59e-05 | 10 | 180 | 3 | 9598303 | |
| Pubmed | Acetylation-dependent regulation of MDM2 E3 ligase activity dictates its oncogenic function. | 1.59e-05 | 10 | 180 | 3 | 28196907 | |
| Pubmed | 1.59e-05 | 10 | 180 | 3 | 25898166 | ||
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | PDGFRA RBM10 ARHGAP11A ESF1 METAP1 NCOR2 GTF2H1 PHF3 UBTF GLYR1 CLTC USP7 PDCD11 UTP20 EIF3A EIF3F SF3A2 | 1.67e-05 | 989 | 180 | 17 | 36424410 |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | EP400 MAP1A LARP1 SPAG9 IFI16 NCOR2 FAM50A PHF3 USP7 CSTA EIF3F | 2.22e-05 | 444 | 180 | 11 | 34795231 |
| Pubmed | TWIST1 and chromatin regulatory proteins interact to guide neural crest cell differentiation. | 2.30e-05 | 109 | 180 | 6 | 33554859 | |
| Pubmed | Generation and analysis of 280,000 human expressed sequence tags. | CACNA1F ESRRG SPATA2 HELQ CXorf65 PHAF1 PBRM1 HP CCNB1IP1 EP300 | 2.42e-05 | 368 | 180 | 10 | 8889549 |
| Pubmed | 2.44e-05 | 225 | 180 | 8 | 12168954 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 28331227 | ||
| Pubmed | Expression of estrogen-related receptors in ovarian cancer and impact on survival. | 2.66e-05 | 2 | 180 | 2 | 34089362 | |
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 30191727 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 11960710 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 33126897 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 38421553 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 10329630 | ||
| Pubmed | Autistic-like behaviours and hyperactivity in mice lacking ProSAP1/Shank2. | 2.66e-05 | 2 | 180 | 2 | 22699619 | |
| Pubmed | Activation and overexpression of Sirt1 attenuates lung fibrosis via P300. | 2.66e-05 | 2 | 180 | 2 | 28365154 | |
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 31052177 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 29727621 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 35384384 | ||
| Pubmed | Selective Localization of Shanks to VGLUT1-Positive Excitatory Synapses in the Mouse Hippocampus. | 2.66e-05 | 2 | 180 | 2 | 27199660 | |
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 19851499 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 8733129 | ||
| Pubmed | HAUSP stabilizes Cdc25A and protects cervical cancer cells from DNA damage response. | 2.66e-05 | 2 | 180 | 2 | 32860838 | |
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 10506216 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 35114313 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 22009748 | ||
| Pubmed | A Tail-Based Mechanism Drives Nucleosome Demethylation by the LSD2/NPAC Multimeric Complex. | 2.66e-05 | 2 | 180 | 2 | 30970244 | |
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 10821841 | ||
| Pubmed | Association of TGIFLX/Y mRNA expression with prostate cancer. | 2.66e-05 | 2 | 180 | 2 | 18663611 | |
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 12226713 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 29097553 | ||
| Pubmed | Association of TGIFLX/Y mRNA expression with azoospermia in infertile men. | 2.66e-05 | 2 | 180 | 2 | 18384077 | |
| Pubmed | The clathrin heavy chain isoform CHC22 functions in a novel endosomal sorting step. | 2.66e-05 | 2 | 180 | 2 | 20065094 | |
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 10072763 | ||
| Pubmed | Involvement of TACE in colon inflammation: a novel mechanism of regulation via SIRT-1 activation. | 2.66e-05 | 2 | 180 | 2 | 24548422 | |
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 28444663 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 19631715 | ||
| Pubmed | Expression profiles of the autism-related SHANK proteins in the human brain. | 2.66e-05 | 2 | 180 | 2 | 37953224 | |
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 36100669 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 36749073 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 20800661 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 23260659 | ||
| Pubmed | SHANK3 in vagal sensory neurons regulates body temperature, systemic inflammation, and sepsis. | 2.66e-05 | 2 | 180 | 2 | 36845137 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | MAP1A UACA EPB41L4B ESRRB ESRRG LARP1 SMC5 PHAF1 PIK3C2A FAM50A PHF3 PIP4K2A TMEM131 CDC27 | 2.71e-05 | 724 | 180 | 14 | 36232890 |
| Interaction | WNK3 interactions | 6.00e-07 | 56 | 178 | 7 | int:WNK3 | |
| Interaction | H3-3A interactions | PDGFRA HMGXB4 SPAG9 ITGA4 ARHGAP11A SMC5 SGO1 ZEB2 SIRT1 NSD3 PBRM1 THYN1 FAM50A PHF3 UBTF GLYR1 CHD5 USP7 KDM1B CDC27 ZHX1 EP300 | 8.09e-07 | 749 | 178 | 22 | int:H3-3A |
| Interaction | AGAP2 interactions | VAPB MAP1A SHANK3 PTK2B SHANK2 AP2A1 AP1B1 PHF3 GNA13 CLTC RIMS2 | 2.76e-06 | 210 | 178 | 11 | int:AGAP2 |
| Interaction | SOX4 interactions | 4.88e-06 | 76 | 178 | 7 | int:SOX4 | |
| Interaction | SUMO2 interactions | TRAF1 ERCC4 EP400 UBR4 HMGXB4 SMC5 SIRT1 PBRM1 PHF3 ASNS CLTC USP7 STIP1 CCNB1IP1 HSF2 ZHX1 EP300 | 2.04e-05 | 591 | 178 | 17 | int:SUMO2 |
| Interaction | AR interactions | EP400 FOLH1 EXPH5 RBM10 LARP1 IDE IFI16 GRHL2 SIRT1 NCOR2 GTF2H1 PBRM1 PPP5C PHF3 UBTF ASNS CLTC USP7 ZFHX3 STIP1 CDC25A CDC27 EP300 | 2.24e-05 | 992 | 178 | 23 | int:AR |
| Interaction | H3C3 interactions | HMGXB4 ITGA4 ARHGAP11A SGO1 ZEB2 NSD3 PBRM1 THYN1 FAM50A PHF3 UBTF GLYR1 CHD5 KDM1B CDC27 | 3.53e-05 | 495 | 178 | 15 | int:H3C3 |
| Interaction | SNAP91 interactions | 3.58e-05 | 70 | 178 | 6 | int:SNAP91 | |
| Interaction | NUP43 interactions | EP400 LARP1 SGO1 IFI16 TTF1 NSD3 NCOR2 PBRM1 UBTF GLYR1 SYNE2 PDCD11 UTP20 ZFHX3 HSF2 ZHX1 ELP4 | 4.11e-05 | 625 | 178 | 17 | int:NUP43 |
| Interaction | FBXO38 interactions | 4.51e-05 | 145 | 178 | 8 | int:FBXO38 | |
| Interaction | ADAR interactions | RIN3 EP400 RBM10 SMC5 IFI16 GLYR1 CHD5 CLTC USP7 STIP1 EP300 | 4.97e-05 | 286 | 178 | 11 | int:ADAR |
| Interaction | BRD1 interactions | MYH6 MAP1A VWA8 IFI16 SIRT1 NCOR2 PBRM1 PPP5C KMT5B CHD5 CLTC CDC27 | 5.80e-05 | 344 | 178 | 12 | int:BRD1 |
| Interaction | SGIP1 interactions | 7.80e-05 | 50 | 178 | 5 | int:SGIP1 | |
| Interaction | PIP4K2C interactions | 8.63e-05 | 159 | 178 | 8 | int:PIP4K2C | |
| Interaction | PPP2R1A interactions | RIN3 CLTCL1 EP400 ESRRB LARP1 SPAG9 ITGA4 SGO1 IFI16 EFR3A PPP5C RHOBTB2 CLTC USP7 STIP1 HSF2 EP300 | 8.81e-05 | 665 | 178 | 17 | int:PPP2R1A |
| Interaction | DDX23 interactions | CERK RBM10 SPAG9 IFI16 ESF1 FAM50A PHF3 UBTF PIP4K2A PDCD11 PIP4K2B UTP20 SF3A2 EP300 | 9.70e-05 | 480 | 178 | 14 | int:DDX23 |
| Interaction | ARX interactions | 1.02e-04 | 28 | 178 | 4 | int:ARX | |
| Interaction | PAX6 interactions | EP400 ESRRG APOB GRHL2 SHANK3 ZEB2 NCOR2 PBRM1 GLYR1 ZFHX3 ZHX1 EP300 | 1.05e-04 | 366 | 178 | 12 | int:PAX6 |
| Interaction | PENK interactions | 1.06e-04 | 11 | 178 | 3 | int:PENK | |
| Interaction | SIRT7 interactions | ANXA6 UBR4 LARP1 SPAG9 TTF1 SIRT1 ESF1 PBRM1 AP1B1 PHF3 UBTF GLYR1 ASNS SYNE2 CLTC USP7 PDCD11 UTP20 | 1.09e-04 | 744 | 178 | 18 | int:SIRT7 |
| Interaction | RPL7A interactions | RIN3 EPB41L4B RBM10 ANXA6 ITGA4 SGO1 IFI16 TTF1 SIRT1 METAP1 NAA35 FAM111A GLYR1 ASNS SYNE2 USP7 STIP1 | 1.13e-04 | 679 | 178 | 17 | int:RPL7A |
| Interaction | POLR1G interactions | EP400 UBR4 TTF1 ZEB2 ESF1 NSD3 PBRM1 FAM50A PHF3 UBTF CLTC USP7 PDCD11 UTP20 | 1.18e-04 | 489 | 178 | 14 | int:POLR1G |
| Interaction | ACSM5 interactions | 1.24e-04 | 55 | 178 | 5 | int:ACSM5 | |
| Interaction | LYAR interactions | ERCC4 ESRRB SMC5 IFI16 TTF1 FAM111A UBTF GLYR1 PIP4K2A EIF3A ZHX1 EP300 | 1.25e-04 | 373 | 178 | 12 | int:LYAR |
| Interaction | ITGB3 interactions | 1.37e-04 | 170 | 178 | 8 | int:ITGB3 | |
| Interaction | CSNK2B interactions | RIN3 EP400 ARFGEF2 ITGA4 SMC5 IFI16 SHANK3 ZEB2 SIRT1 ESF1 PIP4K2A STIP1 EIF3F ZHX1 EP300 SMG6 | 1.41e-04 | 625 | 178 | 16 | int:CSNK2B |
| Interaction | H3C1 interactions | UBR4 HMGXB4 LARP1 SPAG9 ITGA4 NEB ARHGAP11A SMC5 SIRT1 NSD3 PBRM1 FAM50A PHF3 UBTF GLYR1 USP7 ZFHX3 KDM1B CDC27 EP300 | 1.44e-04 | 901 | 178 | 20 | int:H3C1 |
| Interaction | H2BC21 interactions | RIN3 EP400 HMGXB4 NEB IFI16 TTF1 NSD3 ADHFE1 PBRM1 PHF3 GLYR1 USP7 CRYBG1 MICA KDM1B CDC27 EP300 | 1.52e-04 | 696 | 178 | 17 | int:H2BC21 |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 1.05e-04 | 15 | 114 | 3 | 529 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | TPST1 DMXL2 HMGXB4 SPAG9 ARHGAP11A SMC5 ZEB2 EFR3A NCOR2 FCHSD2 PIK3C2A PHF3 SYNE2 PIP4K2A USP7 UTP20 ZFHX3 TMEM131 ADAM17 EIF3A MPHOSPH9 CDC27 ARAP2 FILIP1L | 4.92e-09 | 856 | 179 | 24 | M4500 |
| Coexpression | RODWELL_AGING_KIDNEY_DN | 8.45e-06 | 148 | 179 | 8 | M5408 | |
| Coexpression | RODWELL_AGING_KIDNEY_NO_BLOOD_DN | 8.45e-06 | 148 | 179 | 8 | M11837 | |
| Coexpression | GSE43957_UNTREATED_VS_NACL_TREATED_ANTI_CD3_CD28_STIM_CD4_TCELL_UP | PDGFRA EPB41L4B ZRSR2 ITGA4 SGO1 PAPSS2 OR13J1 SERPINA10 CCNB1IP1 | 1.02e-05 | 200 | 179 | 9 | M9624 |
| Coexpression | BENPORATH_NANOG_TARGETS | VAPB NEBL EXPH5 APOB SPAG9 SNUPN ARHGAP11A PAPSS2 IFI16 TTF1 GRHL2 ZEB2 NSD3 CEPT1 AP2A1 UBP1 GNA13 USP7 MICA EIF3F | 1.50e-05 | 988 | 179 | 20 | M6616 |
| Coexpression | GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_LPS_AND_IL10_STIM_MACROPHAGE_DN | 1.86e-05 | 165 | 179 | 8 | M8121 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN | 2.44e-05 | 84 | 179 | 6 | M13008 | |
| Coexpression | KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP | ZRSR2 GBP3 DNAJB9 ZEB2 KRCC1 ESF1 NSD3 PTK2B GTF2H1 ASNS VPS35L USP7 CSTA PDCD11 UTP20 CCNB1IP1 ARAP2 FILIP1L B4GALT4 | 2.60e-05 | 942 | 179 | 19 | M8144 |
| Coexpression | MURARO_PANCREAS_BETA_CELL | VAPB CERK DMXL2 NEBL MAP1A EXPH5 ARFGEF2 LARP1 DNAJB9 CHN1 PAPSS2 EFR3A NCOR2 PIK3C2A GNA13 SYNE2 CLTC FMN2 ELP4 | 2.76e-05 | 946 | 179 | 19 | M39169 |
| Coexpression | GSE6259_CD4_TCELL_VS_CD8_TCELL_DN | 4.07e-05 | 184 | 179 | 8 | M6739 | |
| Coexpression | GSE43955_1H_VS_42H_ACT_CD4_TCELL_DN | 7.32e-05 | 200 | 179 | 8 | M9665 | |
| Coexpression | GSE3994_WT_VS_PAC1_KO_ACTIVATED_MAST_CELL_DN | 7.32e-05 | 200 | 179 | 8 | M6372 | |
| Coexpression | LINDGREN_BLADDER_CANCER_CLUSTER_2B | TPST1 CERK TRAF1 MAP1A PDGFRA ANXA6 ITGA4 DNAJB9 LIG4 DNAJB5 FILIP1L | 8.01e-05 | 389 | 179 | 11 | M4995 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | CERK TRAF1 EP400 RASA2 ANXA6 UBR4 GBP3 ITGA4 METTL23 SMC5 ZNF831 IFI16 ZEB2 EFR3A PTK2B FAM111A PHF3 UBTF GNA13 PIP4K2A CRYBG1 EIF3F EP300 ARAP2 | 8.41e-05 | 1492 | 179 | 24 | M40023 |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.94e-07 | 136 | 175 | 10 | gudmap_developingGonad_P2_epididymis_1000_k1 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#3_top-relative-expression-ranked_1000 | 8.40e-07 | 123 | 175 | 9 | gudmap_developingGonad_e16.5_epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#4_top-relative-expression-ranked_500 | 8.61e-07 | 91 | 175 | 8 | gudmap_developingGonad_e16.5_epididymis_500_k4 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.34e-06 | 139 | 175 | 9 | gudmap_developingGonad_e18.5_epididymis_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.11e-06 | 184 | 175 | 10 | gudmap_developingGonad_e14.5_ epididymis_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#4_top-relative-expression-ranked_500 | 4.79e-06 | 53 | 175 | 6 | gudmap_developingGonad_P2_epididymis_500_k4 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | VAPB MYH6 ANXA6 HMGXB4 ZEB2 ESF1 NSD3 PTK2B NAA35 ADHFE1 PBRM1 SLC12A2 UBTF GNA13 NRK SYNE2 USP7 EIF3A CCNB1IP1 CDC25A | 1.16e-05 | 806 | 175 | 20 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#5_top-relative-expression-ranked_500 | 2.86e-05 | 72 | 175 | 6 | gudmap_developingGonad_e18.5_epididymis_500_k5 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | DMXL2 ANXA6 HMGXB4 DNAJB9 ZEB2 SIRT1 ESF1 NSD3 NAA35 PBRM1 SLC12A2 GNA13 NRK SYNE2 USP7 ZFHX3 EIF3A CCNB1IP1 CDC25A | 3.78e-05 | 804 | 175 | 19 | gudmap_developingGonad_e12.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#1_top-relative-expression-ranked_1000 | 6.41e-05 | 261 | 175 | 10 | gudmap_developingGonad_e12.5_epididymis_k1_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | CYP4F8 ARFGEF2 HMGCR SMC5 SGO1 CHN1 TTF1 SIRT1 ESF1 FRMD4A LIG4 NAA35 AUNIP SHANK2 PHF3 SYNE2 USP7 UTP20 ZFHX3 STIP1 EIF3A KDM1B HSF2 CDC27 | 1.06e-04 | 1257 | 175 | 24 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#5_top-relative-expression-ranked_500 | 1.07e-04 | 91 | 175 | 6 | gudmap_developingGonad_e14.5_ epididymis_500_k5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_stage III -IV renal corpusc_emap-27945_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.12e-04 | 226 | 175 | 9 | gudmap_developingKidney_e15.5_stage III -IV renal corpusc_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | VAPB ANXA6 HMGXB4 HMGCR ZEB2 ITGB8 ESF1 NSD3 NAA35 PBRM1 SLC12A2 GNA13 NRK SYNE2 USP7 ZFHX3 EIF3A CDC25A | 1.43e-04 | 815 | 175 | 18 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | TPST1 DMXL2 ZRSR2 ARFGEF2 IDE RALGAPA2 SIRT1 ESF1 NEK3 AUNIP PPP5C FAM50A ASNS USP32 KDM1B CCNB1IP1 HSF2 RIMS2 | 1.54e-04 | 820 | 175 | 18 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 1.98e-04 | 192 | 175 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#4_top-relative-expression-ranked_100 | 2.38e-04 | 37 | 175 | 4 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k4_100 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | KANSL1L DMXL2 ZRSR2 ANXA6 HMGXB4 DNAJB9 NEB ITGB8 ESF1 NSD3 NAA35 SLC12A2 GNA13 SYNE2 EIF3A KDM1B CCNB1IP1 | 2.50e-04 | 778 | 175 | 17 | gudmap_developingGonad_e18.5_ovary_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_1000 | ERCC4 PDGFRA ESRRG ARFGEF2 NSD3 EFR3A PIK3C2A PHF3 GNA13 NRK | 2.75e-04 | 312 | 175 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k2 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | VAPB ANXA6 HMGXB4 ITGA4 ZEB2 ITGB8 ESF1 NSD3 NAA35 SLC12A2 UBTF GNA13 NRK SYNE2 USP7 ZFHX3 EIF3A | 3.49e-04 | 801 | 175 | 17 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_500 | 3.68e-04 | 114 | 175 | 6 | gudmap_developingGonad_e12.5_epididymis_k3_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | ERCC4 PDGFRA VWA8 ESRRG ARFGEF2 ITGA4 IFI16 GRHL2 NSD3 EFR3A PIK3C2A PHF3 GNA13 NRK FMN2 PIP4K2B TTLL10 | 3.75e-04 | 806 | 175 | 17 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-06 | 191 | 178 | 8 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-06 | 191 | 178 | 8 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-06 | 194 | 178 | 8 | 93c68c31e39fa44c1d05d7d4997f4f086da4e738 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-06 | 195 | 178 | 8 | 6477e6e7be5bd8eb99119a12ae16334ccddecd43 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.27e-06 | 196 | 178 | 8 | ea8eceacc5d5e1a22b77c31e7c45985dc7bb15de | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.32e-06 | 197 | 178 | 8 | 7e93a97b5ac5ae2f77a4b3141082a1463fed00dd | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 1.48e-06 | 200 | 178 | 8 | edb64556b3fefe3144f73b6efe23b9ffd34091d2 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.48e-06 | 200 | 178 | 8 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-T_cells-TRGV2_gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.42e-06 | 169 | 178 | 7 | 8caf7996796a2e2716e3855de855c903d6126bf2 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.45e-06 | 184 | 178 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.45e-06 | 184 | 178 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.45e-06 | 184 | 178 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Control-T_cells|Control / group, cell type (main and fine annotations) | 1.05e-05 | 187 | 178 | 7 | f4e8e0eba58da89b56587667555a5d4754e108c7 | |
| ToppCell | ILEUM-non-inflamed-(1)_T_cell-(1)_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.12e-05 | 189 | 178 | 7 | 2c8a2fb76ea002bac554bc1c761ce960b5e116e1 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-05 | 191 | 178 | 7 | 96b78b4e819ea6052334bfcbc7abbf35897df885 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-05 | 191 | 178 | 7 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | wk_08-11-Hematologic-Meg-ery-Definitive_erythroblast|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.29e-05 | 193 | 178 | 7 | be75abfdf5301cf33df8ee9ed92504d44fdf19a6 | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.33e-05 | 194 | 178 | 7 | 3d6f2d190dd50804afea299957cc44c2bb756134 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-05 | 194 | 178 | 7 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | Macrophages-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 1.38e-05 | 195 | 178 | 7 | e48bf57e6da23fbb4637a02387155f825455c49f | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.42e-05 | 196 | 178 | 7 | c7136b1c83bcf907eec3b02b151fa061298b6672 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_monocytic-classical_monocyte|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.42e-05 | 196 | 178 | 7 | 28e9e191361966df3a9bd48450090577aa72a999 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.42e-05 | 196 | 178 | 7 | 6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.42e-05 | 196 | 178 | 7 | eea66711a16134f86e6c533a5a837ff2e0d7ca7f | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 1.47e-05 | 197 | 178 | 7 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | LPS_IL1RA|World / Treatment groups by lineage, cell group, cell type | 1.62e-05 | 200 | 178 | 7 | a02fa5b3c4723a6eaa3c685588666c710478dd25 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.62e-05 | 200 | 178 | 7 | 0eb9ad8c0373bcc62029ec21c590ed03aaacd039 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.62e-05 | 200 | 178 | 7 | 851c57187db8bc91a393655bca5f13e787a723d4 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Ductal_and_Papillary_Carcinoma|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.89e-05 | 137 | 178 | 6 | 2a5d2a99a2c532480d00b80a4885514a8a5c80fa | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.67e-05 | 161 | 178 | 6 | e227f7b711475624cf80e77f235b1783d88d57b4 | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.67e-05 | 161 | 178 | 6 | 8280a029026c272cae9649b27575831b0dd4e242 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.84e-05 | 162 | 178 | 6 | 373513f9d0e5007b2e10a8b78d4909dcce9e3b62 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.92e-05 | 168 | 178 | 6 | d823979335ac6b5d1f062ebb741c759d2f919dbf | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-non-classical_monocyte|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.92e-05 | 168 | 178 | 6 | f377ff4c066a9857ad14d245e56325ad220e22e1 | |
| ToppCell | CV-Severe-7|CV / Virus stimulation, Condition and Cluster | 7.66e-05 | 176 | 178 | 6 | 3de0c7d77210049e5616db21eed1490a17a5ec2d | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.93e-05 | 181 | 178 | 6 | aa233b652921848af2257cc3687a7a09c3acfb67 | |
| ToppCell | LV-17._Lymphocyte|LV / Chamber and Cluster_Paper | 8.93e-05 | 181 | 178 | 6 | 81fafa69c8c240250a667a5f3b321e8be1b9a288 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.21e-05 | 182 | 178 | 6 | a8cc56f32efe180e8fb5d69dbe606a794b3db700 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.21e-05 | 182 | 178 | 6 | 5f513bbb7125956eb528e3120de3fd776770a7c3 | |
| ToppCell | COVID-19-lung-AT1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.49e-05 | 183 | 178 | 6 | 7b1a385ed54f93bfe85bf0c162e42d05d516b45c | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-Cd4_positive_Macrophages|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.49e-05 | 183 | 178 | 6 | 92ef926e6c1de8477fa4f35d1dae85482d8009de | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.49e-05 | 183 | 178 | 6 | 24db9cc717e651586317c6a8e03a3401651273c1 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.49e-05 | 183 | 178 | 6 | 2e831a4d99c6f983793df71c0994124c943c6da9 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.78e-05 | 184 | 178 | 6 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.78e-05 | 184 | 178 | 6 | 327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-04 | 186 | 178 | 6 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-04 | 187 | 178 | 6 | c31130fc2f9f882944b2ba366a034a03f051c4b9 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.10e-04 | 188 | 178 | 6 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.10e-04 | 188 | 178 | 6 | 3be2d50148daa4eddddc2c7f269f45c97f7e4931 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.10e-04 | 188 | 178 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | human_hepatoblastoma-NK.T_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.10e-04 | 188 | 178 | 6 | 71b7599e7e1d63cc0c8518c0501533755951d58f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-04 | 188 | 178 | 6 | 2ee64bc73a2251fd9f374be759b442cf4ed0d19e | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-04 | 188 | 178 | 6 | af740fa78542438fdff627ea1f74f4eee43316be | |
| ToppCell | Fetal_29-31_weeks-Immune-natural_killer_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.10e-04 | 188 | 178 | 6 | 6686dbba990066568aa7573e70a7db8b4758f457 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-04 | 188 | 178 | 6 | 4154f4787483c7e076e87a187733a9f666742c3d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.13e-04 | 189 | 178 | 6 | 90aae7e806882bebfad78a78e9a16cf56af3ecd4 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.13e-04 | 189 | 178 | 6 | 975c0f079903ae36b0ffa54e86294d42ec7697de | |
| ToppCell | ASK440-Immune-T_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.13e-04 | 189 | 178 | 6 | 868a387d19eb02bf41933e786b7d23e920a5d433 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.13e-04 | 189 | 178 | 6 | a75226616340045b581d08429d2e123e041dee55 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.13e-04 | 189 | 178 | 6 | 7eb8f5a951e80f1cfac4d7c9eb169f4eb100c917 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.13e-04 | 189 | 178 | 6 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | COVID-19-T_cells-NK_cells|COVID-19 / group, cell type (main and fine annotations) | 1.13e-04 | 189 | 178 | 6 | b699152dfbb8cd8ed724e1e5a51838f29b681b62 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-04 | 190 | 178 | 6 | bf4511395fa97efd1c1cd17cc9bebb0271ee7f0e | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.17e-04 | 190 | 178 | 6 | d153a0bdedcd6865e6ee19575234a78b5d859ff1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-04 | 190 | 178 | 6 | b6b8964b4910083499681b5fdf554e127b6a4c4e | |
| ToppCell | (2)_Fibroblasts-(21)_Fibro-2|(2)_Fibroblasts / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.17e-04 | 190 | 178 | 6 | d2afa08ad868acc6fce308ec21b0bf93591d4010 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.20e-04 | 191 | 178 | 6 | 39220f4a345e328f7fa4fd462a0abeea821b3e02 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-04 | 191 | 178 | 6 | 2fa1b9e76a0ed2d2f0de74349e266cf4a5f51aad | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-04 | 191 | 178 | 6 | 9032aa974aa1b7b1095b8d1b58dcb087358a5001 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-04 | 191 | 178 | 6 | 5717809a1476c20f65bce722c5a57cff92ee0d7a | |
| ToppCell | COVID-19-T_cells|COVID-19 / group, cell type (main and fine annotations) | 1.20e-04 | 191 | 178 | 6 | 7f64add931b64b8d35836fa6bee9ebab593844d3 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMH+-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.23e-04 | 192 | 178 | 6 | fdc741e1846cfd8ed741b160e3c611c310c5d36d | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-04 | 192 | 178 | 6 | ee27d27e3d269764dbe8711d0b37ff9331a298a9 | |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-04 | 192 | 178 | 6 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 1.27e-04 | 193 | 178 | 6 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-04 | 193 | 178 | 6 | f42a0f02ed00fe1bb833ff0a0640d9131bca89bd | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-04 | 193 | 178 | 6 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-DN_to_DP_transition_(most_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 193 | 178 | 6 | a6a864644e1b80b7417ea0a27281e79068a3fd3d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-04 | 193 | 178 | 6 | 42df7ed37d11fb542b4d1d714b6f87ae8e1396a6 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 194 | 178 | 6 | 11709704079f24a730476572dc2f01e9d2226e2c | |
| ToppCell | ILEUM-non-inflamed-(6)_ILC1|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.31e-04 | 194 | 178 | 6 | 396f9a6b370721d425cbe335dbeea5f9514c92dc | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-04 | 194 | 178 | 6 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 194 | 178 | 6 | 3a1f95639d5f239f001bd67d4213e8938e7f299d | |
| ToppCell | LA-08._Macrophage|World / Chamber and Cluster_Paper | 1.31e-04 | 194 | 178 | 6 | c1805572bcc11b1cd29083329d7b5911489fb758 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-04 | 194 | 178 | 6 | 5eaaa81f4b2535f983c424aaef00077089526a5c | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 194 | 178 | 6 | 66c056232ac216780acf4cc8ea325bd8ed1909c9 | |
| ToppCell | human_hepatoblastoma-NK.T_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 1.31e-04 | 194 | 178 | 6 | 997b02a22d7c89a8fd5615bb79a2a8a34fc3fee6 | |
| ToppCell | RA-08._Macrophage|RA / Chamber and Cluster_Paper | 1.31e-04 | 194 | 178 | 6 | ac26e5c71d5069622de72fa25a9c920887ac2c19 | |
| ToppCell | COVID-19_Mild-Neu_3|World / 5 Neutrophil clusters in COVID-19 patients | 1.31e-04 | 122 | 178 | 5 | 2aa9cfadab70312882ae679e3788fc7ab996c0f3 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-04 | 195 | 178 | 6 | 6bdef651cf73d7381e5012d0eb3c809138fb6b92 | |
| ToppCell | P07-Mesenchymal|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.34e-04 | 195 | 178 | 6 | 859764b605866b6c3e6edd0698670ca9c0f20745 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-T_lymphocytic-type_I_NK_T_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.34e-04 | 195 | 178 | 6 | 0a72b8446399807ace5b6c72f865bb40dbd9e92d | |
| ToppCell | LA-08._Macrophage|LA / Chamber and Cluster_Paper | 1.34e-04 | 195 | 178 | 6 | 5e1d5bdb8874091f5a2b1d0a8cc9008165718a97 | |
| ToppCell | ILEUM-non-inflamed-(6)_ILC-(6)_ILC1|(6)_ILC / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.38e-04 | 196 | 178 | 6 | 8a3a63129adfbe58558af91336f81d397c291ed0 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.38e-04 | 196 | 178 | 6 | a7291291931f9e5abd6a54349bc920a0ab68a4cb | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.38e-04 | 196 | 178 | 6 | c2bbb48c4aa979b03cb6f4ce9f351f492977c992 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.38e-04 | 196 | 178 | 6 | 64c2abc0087bf2ae547932377f3662e3be1cc63e | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 1.38e-04 | 196 | 178 | 6 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| ToppCell | mLN-B_cell-B_cell_cycling|B_cell / Region, Cell class and subclass | 1.42e-04 | 197 | 178 | 6 | 2071526fe46de8359ea118ff78581eb4454aa55a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.42e-04 | 197 | 178 | 6 | c9b1f2ee7eb31a66af331c5aae29e1bbb5186f5a | |
| Drug | AC1L22FJ | FOLH1 ESRRB ESRRG HMGCR IDE NCOR2 ADHFE1 PBRM1 PIP4K2B MPHOSPH9 EP300 | 1.04e-06 | 213 | 179 | 11 | CID000013766 |
| Drug | Acetohexamide [968-81-0]; Down 200; 12.4uM; HL60; HT_HG-U133A | KANSL1L TRAF1 CLTCL1 PTK2B GLYR1 ADAM17 EIF3A CFAP44 EP300 MMUT | 3.80e-06 | 197 | 179 | 10 | 1870_DN |
| Drug | Cephaeline dihydrochloride heptahydrate [6487-30-5]; Down 200; 6uM; HL60; HT_HG-U133A | 8.76e-06 | 171 | 179 | 9 | 2429_DN | |
| Drug | AC1Q6PMK | 1.69e-05 | 41 | 179 | 5 | CID000000775 | |
| Drug | Prochlorperazine dimaleate [84-02-6]; Down 200; 6.6uM; MCF7; HT_HG-U133A | 1.72e-05 | 186 | 179 | 9 | 5010_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HG-U133A | 1.87e-05 | 188 | 179 | 9 | 1421_DN | |
| Drug | Benzbromarone [3562-84-3]; Up 200; 9.4uM; HL60; HT_HG-U133A | 1.95e-05 | 189 | 179 | 9 | 1291_UP | |
| Drug | Carteolol hydrochloride [51781-21-6]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 2.40e-05 | 194 | 179 | 9 | 4176_DN | |
| Drug | Na 7 | 2.60e-05 | 8 | 179 | 3 | CID000446006 | |
| Drug | Liothyronine [6893-02-3]; Down 200; 6.2uM; PC3; HT_HG-U133A | 2.60e-05 | 196 | 179 | 9 | 6602_DN | |
| Drug | nocodazole | TPST1 MYH6 CLTCL1 MAP1A ARFGEF2 SGO1 PTK2B NEK3 PPP5C NRK CLTC EIF3A CDC25A CDC27 | 2.63e-05 | 477 | 179 | 14 | CID000004122 |
| Drug | Zalcitabine [7481-89-2]; Down 200; 19uM; MCF7; HT_HG-U133A | 2.71e-05 | 197 | 179 | 9 | 7352_DN | |
| Drug | Diphemanil methylsulfate [62-97-5]; Up 200; 10.2uM; HL60; HG-U133A | 2.93e-05 | 199 | 179 | 9 | 1994_UP | |
| Drug | Methiothepin maleate [19728-88-2]; Down 200; 8.4uM; PC3; HT_HG-U133A | 2.93e-05 | 199 | 179 | 9 | 6312_DN | |
| Drug | celecoxib; Down 200; 10uM; MCF7; HG-U133A | 3.05e-05 | 200 | 179 | 9 | 377_DN | |
| Disease | melanoma | ERCC4 RASA2 PDGFRA UBR4 ZNF831 PTK2B PIP4K2A CRYBG1 STIP1 EP300 | 2.49e-06 | 248 | 175 | 10 | C0025202 |
| Disease | Paroxysmal atrial fibrillation | 4.24e-05 | 156 | 175 | 7 | C0235480 | |
| Disease | familial atrial fibrillation | 4.24e-05 | 156 | 175 | 7 | C3468561 | |
| Disease | Persistent atrial fibrillation | 4.24e-05 | 156 | 175 | 7 | C2585653 | |
| Disease | Atrial Fibrillation | 4.98e-05 | 160 | 175 | 7 | C0004238 | |
| Disease | total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality, cancer | 5.73e-05 | 69 | 175 | 5 | EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004340, EFO_0004348, EFO_0004352, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928, MONDO_0004992 | |
| Disease | pulse pressure measurement | FUT10 MYH6 TRAF1 RIN3 NEBL PDGFRA FOLH1 LEKR1 MEI1 PKD1L3 ZNF831 FAM186B NSD3 PBRM1 SLC12A2 PIK3C2A PIP4K2A ZFHX3 CDC25A FILIP1L SMG6 | 8.36e-05 | 1392 | 175 | 21 | EFO_0005763 |
| Disease | calcium measurement | ANKRD31 MAP1A ASIC2 LEKR1 ESRRG HMGCR METAP1 SLC12A2 UBTF SYNE2 CSTA ZFHX3 TMEM131 | 1.03e-04 | 628 | 175 | 13 | EFO_0004838 |
| Disease | haptoglobin measurement | 2.52e-04 | 21 | 175 | 3 | EFO_0004640 | |
| Disease | atrial fibrillation | 3.94e-04 | 371 | 175 | 9 | EFO_0000275 | |
| Disease | hypertension (biomarker_via_orthology) | 4.31e-04 | 227 | 175 | 7 | DOID:10763 (biomarker_via_orthology) | |
| Disease | free cholesterol in very large VLDL measurement | 4.79e-04 | 61 | 175 | 4 | EFO_0022274 | |
| Disease | reading and spelling ability | 4.84e-04 | 166 | 175 | 6 | EFO_0005301 | |
| Disease | cholesterol to total lipids in small LDL percentage | 5.40e-04 | 27 | 175 | 3 | EFO_0022241 | |
| Disease | cholesterol to total lipids in medium LDL percentage | 5.40e-04 | 27 | 175 | 3 | EFO_0022238 | |
| Disease | reticulocyte measurement | RASA2 C6orf89 VWA8 ARFGEF2 LARP1 ITGA4 SGO1 ZEB2 SLC12A2 AP1B1 GNA13 SYNE2 USP32 TMEM131 MICA SMG6 | 5.63e-04 | 1053 | 175 | 16 | EFO_0010700 |
| Disease | non-alcoholic fatty liver disease (biomarker_via_orthology) | 6.10e-04 | 65 | 175 | 4 | DOID:0080208 (biomarker_via_orthology) | |
| Disease | breast carcinoma (is_marker_for) | 6.47e-04 | 66 | 175 | 4 | DOID:3459 (is_marker_for) | |
| Disease | LDL cholesterol change measurement | 7.20e-04 | 7 | 175 | 2 | EFO_0007804 | |
| Disease | glycosyl ceramide (d18:1/20:0, d16:1/22:0) measurement | 7.20e-04 | 7 | 175 | 2 | EFO_0800551 | |
| Disease | atrioventricular septal defect (implicated_via_orthology) | 7.20e-04 | 7 | 175 | 2 | DOID:0050651 (implicated_via_orthology) | |
| Disease | free cholesterol in large VLDL measurement | 7.24e-04 | 68 | 175 | 4 | EFO_0022265 | |
| Disease | memory impairment | 9.57e-04 | 8 | 175 | 2 | EFO_0001072 | |
| Disease | myocardial infarction | 1.21e-03 | 350 | 175 | 8 | EFO_0000612 | |
| Disease | Burkitt Lymphoma | 1.27e-03 | 36 | 175 | 3 | C0006413 | |
| Disease | Cardiovascular Diseases | 1.27e-03 | 36 | 175 | 3 | C0007222 | |
| Disease | colorectal health | 1.31e-03 | 201 | 175 | 6 | EFO_0008460 | |
| Disease | fish oil supplement exposure measurement, triglyceride measurement | 1.53e-03 | 10 | 175 | 2 | EFO_0004530, EFO_0600007 | |
| Disease | cardiovascular system disease (is_marker_for) | 1.53e-03 | 10 | 175 | 2 | DOID:1287 (is_marker_for) | |
| Disease | nephritis (implicated_via_orthology) | 1.53e-03 | 10 | 175 | 2 | DOID:10952 (implicated_via_orthology) | |
| Disease | triglycerides to total lipids in large VLDL percentage | 1.60e-03 | 39 | 175 | 3 | EFO_0022332 | |
| Disease | platelet crit | ANKRD31 RIN3 MAP1A C6orf89 EXPH5 LEKR1 APOB HMGCR METAP1 USP7 FMN2 EIF3A MPHOSPH9 SMG6 | 1.69e-03 | 952 | 175 | 14 | EFO_0007985 |
| Disease | free cholesterol in medium LDL measurement | 1.72e-03 | 40 | 175 | 3 | EFO_0022268 | |
| Disease | liver fibrosis measurement | 1.74e-03 | 86 | 175 | 4 | EFO_0010576 | |
| Disease | beta thalassemia (is_marker_for) | 1.86e-03 | 11 | 175 | 2 | DOID:12241 (is_marker_for) | |
| Disease | Autoimmune Diseases | 1.99e-03 | 42 | 175 | 3 | C0004364 | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 2.05e-03 | 150 | 175 | 5 | EFO_0004611, EFO_0020947 | |
| Disease | sleep duration, low density lipoprotein cholesterol measurement | 2.14e-03 | 91 | 175 | 4 | EFO_0004611, EFO_0005271 | |
| Disease | low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 2.24e-03 | 153 | 175 | 5 | EFO_0004611, EFO_0020944 | |
| Disease | total cholesterol measurement, very low density lipoprotein cholesterol measurement | 2.26e-03 | 224 | 175 | 6 | EFO_0004574, EFO_0008317 | |
| Disease | cholesterol to total lipids in large VLDL percentage | 2.42e-03 | 45 | 175 | 3 | EFO_0022236 | |
| Disease | middle cerebral artery infarction (implicated_via_orthology) | 2.42e-03 | 45 | 175 | 3 | DOID:3525 (implicated_via_orthology) | |
| Disease | osteoarthritis, knee | 2.57e-03 | 158 | 175 | 5 | EFO_0004616 | |
| Disease | myeloid leukemia (is_implicated_in) | 2.61e-03 | 13 | 175 | 2 | DOID:8692 (is_implicated_in) | |
| Disease | Hyperlipoproteinemia Type IIb | 2.61e-03 | 13 | 175 | 2 | C1704417 | |
| Disease | Gastrointestinal Stromal Sarcoma | 2.75e-03 | 47 | 175 | 3 | C3179349 | |
| Disease | cholesteryl esters to total lipids in small VLDL percentage | 3.09e-03 | 49 | 175 | 3 | EFO_0022256 | |
| Disease | breast carcinoma | RIN3 NEBL RASA2 LEKR1 ESRRG SNUPN GRHL2 FRMD4A SLC12A2 KMT5B PIP4K2A HSF2 FILIP1L SMG6 | 3.13e-03 | 1019 | 175 | 14 | EFO_0000305 |
| Disease | Gastrointestinal Stromal Tumors | 3.28e-03 | 50 | 175 | 3 | C0238198 | |
| Disease | free cholesterol in LDL measurement | 3.28e-03 | 50 | 175 | 3 | EFO_0022266 | |
| Disease | free cholesterol in large LDL measurement | 3.47e-03 | 51 | 175 | 3 | EFO_0022176 | |
| Disease | total cholesterol measurement, diastolic blood pressure, triglyceride measurement, systolic blood pressure, hematocrit, ventricular rate measurement, glucose measurement, body mass index, high density lipoprotein cholesterol measurement | 3.47e-03 | 51 | 175 | 3 | EFO_0004340, EFO_0004348, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928 | |
| Disease | infant head circumference | 3.49e-03 | 15 | 175 | 2 | EFO_0004577 | |
| Disease | upper aerodigestive tract neoplasm | 3.59e-03 | 246 | 175 | 6 | EFO_0004284 | |
| Disease | phospholipids in IDL measurement | 3.66e-03 | 52 | 175 | 3 | EFO_0022164 | |
| Disease | hair colour measurement | TRAF1 RIN3 RASA2 ASIC2 FOLH1 MROH2A PKD1L3 ZNF831 SYNE2 FMN2 | 3.83e-03 | 615 | 175 | 10 | EFO_0007822 |
| Disease | congestive heart failure (biomarker_via_orthology) | 3.84e-03 | 107 | 175 | 4 | DOID:6000 (biomarker_via_orthology) | |
| Disease | phospholipids in large LDL measurement | 3.86e-03 | 53 | 175 | 3 | EFO_0022174 | |
| Disease | triglycerides to total lipids in very large VLDL percentage | 3.86e-03 | 53 | 175 | 3 | EFO_0022340 | |
| Disease | Prostatic Neoplasms | TRAF1 FOLH1 SIRT1 SLC12A2 THYN1 USP7 ZFHX3 EIF3A CDC27 B4GALT4 | 3.88e-03 | 616 | 175 | 10 | C0033578 |
| Disease | Malignant neoplasm of prostate | TRAF1 FOLH1 SIRT1 SLC12A2 THYN1 USP7 ZFHX3 EIF3A CDC27 B4GALT4 | 3.88e-03 | 616 | 175 | 10 | C0376358 |
| Disease | Hyperlipoproteinemia Type IIa | 3.97e-03 | 16 | 175 | 2 | C0745103 | |
| Disease | behavioural inhibitory control measurement | 3.97e-03 | 16 | 175 | 2 | EFO_0008467 | |
| Disease | diabetic retinopathy (implicated_via_orthology) | 3.97e-03 | 16 | 175 | 2 | DOID:8947 (implicated_via_orthology) | |
| Disease | Diffuse Large B-Cell Lymphoma | 4.29e-03 | 55 | 175 | 3 | C0079744 | |
| Disease | pathological myopia | 4.37e-03 | 111 | 175 | 4 | EFO_0004207 | |
| Disease | schizophrenia, irritable bowel syndrome | 4.49e-03 | 17 | 175 | 2 | EFO_0000555, MONDO_0005090 | |
| Disease | sphingomyelin 14:0 measurement | 4.49e-03 | 17 | 175 | 2 | EFO_0010390 | |
| Disease | cholesteryl esters to total lipids in large VLDL percentage | 4.51e-03 | 56 | 175 | 3 | EFO_0022250 | |
| Disease | pancreatic cancer (is_implicated_in) | 4.52e-03 | 112 | 175 | 4 | DOID:1793 (is_implicated_in) | |
| Disease | total lipids in large LDL | 4.74e-03 | 57 | 175 | 3 | EFO_0022163 | |
| Disease | cholesterol in large LDL measurement | 4.74e-03 | 57 | 175 | 3 | EFO_0021901 | |
| Disease | Malignant neoplasm of breast | UBR4 ARFGEF2 ARHGAP11A HELQ ZEB2 SIRT1 ADHFE1 PBRM1 HP CHD5 SYNE2 UTP20 CDC27 EP300 | 4.96e-03 | 1074 | 175 | 14 | C0006142 |
| Disease | cholesterol in IDL measurement | 4.98e-03 | 58 | 175 | 3 | EFO_0021899 | |
| Disease | sweet liking measurement | 5.03e-03 | 18 | 175 | 2 | EFO_0010156 | |
| Disease | Tourette syndrome, schizophrenia | 5.03e-03 | 18 | 175 | 2 | EFO_0004895, MONDO_0005090 | |
| Disease | Hypercholesterolemia, Familial | 5.03e-03 | 18 | 175 | 2 | C0020445 | |
| Disease | coronary artery disease | ANKRD31 EXOC6 CLTCL1 ASIC2 ARFGEF2 APOB HMGCR PKD1L3 SPATA2 ZNF831 ZEB2 FMN2 PIP4K2B CDC25A SMG6 | 5.14e-03 | 1194 | 175 | 15 | EFO_0001645 |
| Disease | phospholipids in VLDL measurement | 5.23e-03 | 59 | 175 | 3 | EFO_0022301 | |
| Disease | free cholesterol to total lipids in very large VLDL percentage | 5.23e-03 | 59 | 175 | 3 | EFO_0022289 | |
| Disease | total lipids in IDL | 5.48e-03 | 60 | 175 | 3 | EFO_0022161 | |
| Disease | total lipids in VLDL measurement | 5.48e-03 | 60 | 175 | 3 | EFO_0022314 | |
| Disease | glycoprotein measurement | 5.59e-03 | 119 | 175 | 4 | EFO_0004555 | |
| Disease | emphysema pattern measurement | 5.60e-03 | 19 | 175 | 2 | EFO_0005850 | |
| Disease | glomerulonephritis (is_marker_for) | 5.60e-03 | 19 | 175 | 2 | DOID:2921 (is_marker_for) | |
| Disease | complex trait | 5.72e-03 | 271 | 175 | 6 | EFO_0010578 | |
| Disease | free cholesterol in IDL measurement | 5.74e-03 | 61 | 175 | 3 | EFO_0022181 | |
| Disease | free cholesterol in VLDL measurement | 5.74e-03 | 61 | 175 | 3 | EFO_0022276 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DLKANKTFAYHKDMP | 56 | O60507 | |
| KKKSNHQEFEAVAMP | 336 | Q15361 | |
| KPNGKVASVEMVKYH | 191 | P08243 | |
| LHYCKDKAKDFMPAS | 1361 | Q86US8 | |
| SQKLYATMEKHKEVF | 1581 | Q09472 | |
| MDFLAFKKKHYAPLQ | 401 | Q96L91 | |
| KMALKYHPDKNKEPN | 26 | O75953 | |
| MLFLMKPNHAEYASK | 51 | A6NEN9 | |
| PFKSEVHKGNYLEMK | 1771 | Q8TDI0 | |
| IPKAKEFMANFHKTL | 41 | O60513 | |
| TKFMQLHFPKTYLKD | 2501 | Q86UK0 | |
| LKINDEKFKAHASMY | 1721 | Q9Y6D5 | |
| KIFKANHPMDAEVTK | 891 | O95782 | |
| MQDIPIYANVHKTKK | 71 | Q8WZ64 | |
| ILKHEMKVFFVKYND | 316 | Q10567 | |
| DFIIGYKPHKEDMEK | 856 | Q8TDJ6 | |
| QISPANIKKKVYHMD | 651 | Q8IYM0 | |
| FHKLAMKYHPDKNKS | 46 | Q9UBS3 | |
| MKYHPDKNKSPDAEA | 51 | Q9UBS3 | |
| NEKLPKHMQFKRTDF | 966 | Q96MT7 | |
| MLPKSLEKHEKDLYF | 646 | Q14156 | |
| EKPNNHLNKFKGYME | 241 | O94823 | |
| PAHYDAKQLKKAMEG | 436 | P08133 | |
| FIKMTNYDVEHTIKK | 566 | P08133 | |
| ANFKHYKPKQFSMLE | 141 | Q16515 | |
| KVSMHYSDPKPKINE | 201 | P98175 | |
| KKNMFQVIHTEKPLY | 671 | Q15283 | |
| VQPKAMKIEKSFDAH | 1071 | O60271 | |
| RNFLKEDAMKTKTHY | 166 | Q29983 | |
| DTVHQMKPYLKKSVS | 1646 | Q8N7Z5 | |
| YNKIKSGYRMAKPDH | 906 | P16234 | |
| EMVLKIIAFKPKHYF | 1236 | O60840 | |
| EKETFREKFMQHPKN | 436 | Q9Y618 | |
| NKAKKAMDFYDPARH | 556 | O95340 | |
| HFNKKMYEEFKQLAL | 926 | Q6PKG0 | |
| ETEHEPTKMFYKKEV | 1201 | Q86U86 | |
| HHPKKQSDGMEEYKT | 961 | A0AUZ9 | |
| MNRHFSKEDIYAAKK | 1076 | O00370 | |
| LMKKFEYSPSKVHLI | 151 | Q17RR3 | |
| VPHYAKNKAVGVMKS | 306 | P53582 | |
| KAEGFYQKHMQEPLK | 676 | P78559 | |
| KFTDHLKYVMLPVAD | 291 | P00738 | |
| YLILHEFKAMEEKVK | 31 | Q6ZMV7 | |
| PASMNYAKAHSKDKK | 181 | Q9NQ76 | |
| KALSKLHEYFPEMQI | 666 | P04035 | |
| NKMQEKLFKEHVFIY | 171 | Q4FZB7 | |
| KYADKIYSISMKHPQ | 606 | Q04609 | |
| TEMKEESVKKHQYPD | 416 | Q7L5Y1 | |
| MFHDKKFKLNYAVDK | 41 | Q9H501 | |
| STAPKMIYDLFRKHK | 76 | Q8NGB9 | |
| NKHLYQIEKPCKEAM | 531 | O00443 | |
| KVEQLKPYHAHKEEM | 56 | Q49A26 | |
| NLYKSKDPKEFMEHI | 56 | Q99550 | |
| KDTSKMYIPHTDKSN | 776 | Q8NEV8 | |
| DILATIYFLMHKNPK | 111 | Q86XA0 | |
| YMKNSFKDVDHLFQK | 366 | Q9H0R5 | |
| IHEYDFEIKNVPFKM | 206 | Q14344 | |
| SHKSKKMKPLYVNTE | 166 | Q9UGU5 | |
| IFMYLKPKSKEAHIS | 256 | Q8NGT2 | |
| DVMKDISKHYSQKAA | 436 | Q6ZMI0 | |
| KNHMFFIAITKKPEV | 1776 | Q2PPJ7 | |
| EMKTKHKAYENAVGI | 991 | Q08378 | |
| VYDDQPNAHKKFMEK | 36 | Q8TAG9 | |
| KMKHPNIVAFKESFE | 56 | P51956 | |
| ALKHKTPEVHLKYAM | 1136 | Q9UG01 | |
| NLFVIVPHMKEKFSK | 581 | Q5TIA1 | |
| KEPQTKLHQQFEMYK | 86 | Q9UQ26 | |
| AEANFMLKVHPLKKY | 131 | P26012 | |
| YHRNDYDKSPIKPKM | 596 | Q9P2Q2 | |
| DMLIKKLKSFDYHQF | 2421 | P04114 | |
| AMIYKKSAVQLFEKH | 301 | Q9Y6K0 | |
| KKSDITYFKTMPDLH | 461 | Q6ISB3 | |
| VFYDMDPQKKHSVLM | 696 | Q8NB78 | |
| KDMKHQSFYIETKLD | 261 | P49917 | |
| HVDEKAPMKYKTAVQ | 141 | Q6ZNI0 | |
| YRKTHVEKKTPFIDM | 126 | Q9HCG7 | |
| EFAKNMYELHKKVSP | 151 | O00303 | |
| PALDVLYDVMKSKKH | 26 | Q14152 | |
| MERGAKEKNHQLYKP | 61 | Q86UL3 | |
| YEKPMNELDKVVEKH | 136 | Q4L180 | |
| QKMEKPYAFTVHCVK | 76 | Q8TCT0 | |
| KMEEAPTHLNSFLKK | 51 | Q6P4F1 | |
| YNIKLEGKVPMHKLF | 436 | P62508 | |
| KCNMKIEHYFSPVSK | 16 | Q96PZ2 | |
| MKSNIDKKFSAHYDA | 41 | Q14320 | |
| HFNILKPYMKIFNKS | 156 | Q9HBI6 | |
| KPYIKIFSKSANIMH | 161 | P98187 | |
| DNKYMHLKVFKSLPG | 61 | P01040 | |
| YEPKEQKKMFHATVA | 591 | Q16666 | |
| KPHENKTYLAVGSMK | 641 | P13612 | |
| MKHSKKTYDSFQDEL | 1 | Q9NPI7 | |
| QDHLDKAKKDITFYM | 121 | P38567 | |
| EHMLFLGTKKYPKEN | 111 | P14735 | |
| LKSPSHMEKYPQKEK | 916 | Q9Y4K1 | |
| HMEKYPQKEKTKEDL | 921 | Q9Y4K1 | |
| VYNHKTPESNIKMKI | 146 | Q96EB1 | |
| YSVKLQGKVPMHKLF | 411 | O95718 | |
| GKKKYFETEQMAHAV | 151 | O94868 | |
| LEQKYMQLPEHKKHA | 126 | Q8TDG4 | |
| FFKDMPHNALDKKSN | 186 | Q14289 | |
| AYKKHMPVLKETHDE | 156 | P15882 | |
| IAKKYMSENKGVPLH | 111 | Q6UWU4 | |
| KVYQVSSKEHMQPFK | 1596 | Q9NZ56 | |
| YKQEKFSLAEMHFQK | 646 | P30260 | |
| IKKQMKIGPAYALHF | 146 | Q9H329 | |
| KQVEQYMSFHKLPAD | 481 | Q9UL51 | |
| EFLKKYMHKVMNDLP | 306 | B1AKI9 | |
| KKDMNETFREKFPHV | 341 | Q9BTV7 | |
| KNYQSMEKHTKLPGD | 206 | Q9H7T9 | |
| KENMPSHFKFKEYCP | 81 | P48426 | |
| YRPMHHEDFKEDLKK | 486 | P30304 | |
| KILQKFTSMHKAYSP | 741 | Q8TB24 | |
| KEILPKYFKHNNMAS | 46 | Q03933 | |
| KMYKAKDYNVDHPLV | 341 | Q8IWW8 | |
| DMNSADPFHLKYIIK | 96 | Q6ZUA9 | |
| MKQMSTHYLKKLDFP | 1616 | A6NES4 | |
| CKKPLIHMYEKEFTS | 1196 | Q7Z2Y5 | |
| YAMTPIFDEKMLKHE | 1616 | O75691 | |
| KDIHSNMPKDYLSKQ | 701 | Q6P4F7 | |
| KHRFKAYPSEEEKQM | 71 | Q8IUE1 | |
| KHRFKAYPSEEEKQM | 71 | Q8IUE0 | |
| KHYDKAKELDPTNMT | 246 | P31948 | |
| PFDLHAMQNIILKYK | 1291 | Q8WXH0 | |
| YQPKFKTEKEFMQHA | 46 | Q9BRJ2 | |
| EKMLISSIKEKYPSH | 51 | P29218 | |
| KPHDKDAKMKYQECN | 126 | P53041 | |
| VDVYAMKSHESSPKK | 346 | P78356 | |
| KAMSPENQEYFEKHR | 651 | Q9BYZ6 | |
| VMPLKKHQDNKYPAD | 86 | Q7Z443 | |
| PQKKMHKSVSSNDAY | 321 | Q5FBB7 | |
| ENLPEQFHRAMKYDK | 416 | Q96EB6 | |
| MDIDTVKKLPKHYAN | 86 | O95149 | |
| DMTFKAKLYDNHLGK | 546 | P13533 | |
| MLGSPHKVFYKSEDK | 251 | Q9BSU1 | |
| ETIDINKDPYFMKNH | 36 | Q15428 | |
| KMKPIIHKSNALYQD | 1551 | Q9UPX8 | |
| KHYNMAKSYPNEEKD | 296 | P78536 | |
| FSKAEGHLKQMEKIY | 111 | Q9NPC3 | |
| AILYSKFKPQKMREH | 1321 | Q00610 | |
| AILYSKFKPQKMLEH | 1321 | P53675 | |
| PDHALVKKYMKLQHV | 281 | Q8IV77 | |
| ADILMKNPEKKYHIG | 486 | Q14690 | |
| KYAENVPHNMTEKEF | 206 | P32780 | |
| PCYKKSELHKFMPNN | 491 | Q9UM82 | |
| EYIKKQSKQPDMTHL | 936 | Q7Z3J2 | |
| DKEPLTAYNYKKQMH | 386 | Q9UNW1 | |
| PVHYLQFKEMSDLNK | 631 | Q5VZE5 | |
| LKKFMDYVQLHSTDK | 116 | Q9BYB0 | |
| LIKNKMKAFYAPVHA | 846 | P55011 | |
| EAKTMFKVHNFSKPV | 476 | Q92545 | |
| YKAHVMSSLKQGKEP | 86 | A6NDX5 | |
| NLKYHPGEENFKLTM | 121 | Q9UKY1 | |
| VKEEVCMSLKPEYHK | 181 | Q92576 | |
| PKHAYVKDDTMFLKC | 396 | Q13077 | |
| KIKTEPKQMHEDYCF | 1311 | Q9BZ95 | |
| FFPKFKLDQKYEMHE | 336 | Q9UK55 | |
| IFHIYLKAKKMTTFE | 256 | Q9H8X9 | |
| YEFLLMKVEKDHLAK | 381 | A8K0R7 | |
| KNHYVPLKVSEDMKK | 741 | Q9BZF9 | |
| LMKIVKEAYPDHTQF | 126 | Q9P016 | |
| MEKRTAHEKEKYQPS | 251 | Q9NZI7 | |
| DFMKKSPFHEHIKTD | 206 | Q86WZ6 | |
| TGEKFYEHNKNMKAL | 221 | Q9Y2H8 | |
| FDYDPNEKSKHKFMV | 76 | O95292 | |
| ARVYHLPDAKMSKKE | 341 | Q92889 | |
| RNNMEASVPKYKKHL | 21 | Q1A5X7 | |
| ETFKRIYQKMKASPH | 626 | Q5JPB2 | |
| IFHIYLKAKKMTTFE | 256 | P0C7U3 | |
| EEISKLKGYHMKDPC | 481 | O60315 | |
| KRAKYAKLHPEMSNL | 126 | P17480 | |
| KMKVPDVLFYDNIQH | 746 | A3KMH1 | |
| MKDNKNAKYIENHIP | 491 | Q8IY18 | |
| ALDYMKKHIPSAKNL | 4691 | Q5T4S7 | |
| FMQKKSPLYMLLKEH | 421 | Q6ZVT0 | |
| KDHDVMLFLKMYDPK | 681 | Q93009 | |
| KMTFPEKPSHKKYRA | 6 | Q15696 | |
| DPKMVELAKYAKQHV | 606 | Q9H3U1 | |
| YAQFLPKTDGKKMAD | 1571 | Q8NFA0 | |
| KYQQTLEAHMKEKHP | 681 | Q15911 | |
| KKMAYQKVHADQRAP | 16 | Q58DX5 | |
| IIADIFEYTAKHMPK | 241 | P22033 | |
| EKEIFEGPKYKMHID | 1281 | P52179 | |
| DNEMKDKKHHYNPLE | 236 | O76041 | |
| NVKYKKDIQNMHDPV | 266 | O76041 | |
| EKTKSKYNTPHDMFN | 1131 | P20929 | |
| DYHKTKAKINIPADM | 4291 | P20929 |